SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4945-4951

  Buchholz, Malte ^a   Biebl, Anja ^a   Neeße, Albrecht ^a   Wagner, Martin ^a   Iwamura, Takeshi ^b   Leder, Gerhard ^c   Adler, Guido ^a   Gress, Thomas M ^a,c  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; DOXYCYCLINE; FIBRONECTIN; LAMININ; PROTEASE NEXIN I; RNA; SERINE PROTEINASE INHIBITOR; THYMIDINE; TRITIUM; UROKINASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INVASION; CELL INTERACTION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GASTROINTESTINAL TUMOR; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG; METASTASIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STROMA CELL; WESTERN BLOTTING; XENOGRAFT;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CARRIER PROTEINS; EXTRACELLULAR MATRIX; FEMALE; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PANCREAS; PANCREATIC NEOPLASMS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTORS, CELL SURFACE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0042440692     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Iwamura, T., Katsuki, T., and Ide, K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn. J. Cancer Res., 78: 54-62, 1987.
2. Iwamura, T., Caffrey, T. C., Kitamura, N., Yamanari, H., Setoguchi, T., and Hollingsworth, M. A. P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Res., 57: 1206-1212, 1997.
3. Taniguchi, S., Iwamura, T., and Katsuki, T. Correlation between spontaneous metastatic potential and type I collagenolytic activity in a human pancreatic cancer cell line (SUIT-2) and sublines. Clin. Exp. Metastasis, 10: 259-266, 1992.
4. Strathdee, C. A., McLeod, M. R., and Hall, J. R. Efficient control of tetracycline-responsive gene expression from an autoregulated bi-directional expression vector. Gene (Amst.), 229: 21-29, 1999.
5. Wenger, C., Ellenrieder, V., Alber, B., Lacher, U., Menke, A., Hameister, H., Wilda, M., Iwamura, T., Beger, H. G., Adler, G., and Gress, T. M. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene, 18: 1073-1080, 1999.
6. Gress, T. M., Muller-Pillasch, F., Geng, M., Zimmerhackl, F., Zehetner, G., Friess, H., Buchler, M., Adler, G., and Lehrach, H. A pancreatic cancer-specific expression profile. Oncogene, 13: 1819-1830, 1996.
7. Giehl, K., Skripczynski, B., Mansard, A., Menke, A., and Gierschik, P. Growth factor-dependent activation of the Ras-Raf-MEK-MAPK pathway in the human pancreatic carcinoma cell line PANC-1 carrying activated K-ras: implications for cell proliferation and cell migration. Oncogene, 19: 2930-2942, 2000.
8. Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., and Gress, T. M. TGF-β-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system. Int. J. Cancer, 93: 204-211, 2001.
9. Giehl, K., Seidel, B., Gierschik, P., Adler, G., and Menke, A. TGFβ1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation. Oncogene, 19: 4531-4541, 2000.
10. Ellenrieder, V., Alber, B., Lacher, U., Hendler, S. F., Menke, A., Boeck, W., Wagner, M., Wilda, M., Friess, H., Buchler, M., Adler, G., and Gress, T. M. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer, 85: 14-20, 2000.
11. Gress, T. M., Menke, A., Bachem, M., Muller-Pillasch, F., Ellenrieder, V., Weidenbach, H., Wagner, M., and Adler, G. Role of extracellular matrix in pancreatic diseases. Digestion, 59: 625-637, 1998.
12. Engers, R., and Gabbert, H. E. Mechanisms of tumor metastasis: cell biological aspects and clinical implications. J. Cancer Res. Clin. Oncol., 126: 682-692, 2000.
13. Meier, R., Spreyer, P., Ortmann, R., Harel, A., and Monard, D. Induction of glia-derived nexin after lesion of a peripheral nerve. Nature (Lond.), 342: 548-550, 1989.
14. Zurn, A. D., Nick, H., and Monard, D. A glia-derived nexin promotes neurite outgrowth in cultured chick sympathetic neurons. Dev. Neurosci., 10: 17-24, 1988.
15. Duffy, M. J., Maguire, T. M., McDermott, E. W., and O'Higgins, N. Urokinase plasminogen activator: a prognostic marker in multiple types of cancer. J. Surg. Oncol., 71: 130-135, 1999.
16. Bramhall, S. R. The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application. Int. J. Pancreatol., 21: 1-12, 1997.
17. Hidalgo, M., and Eckhardt, S. G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst. (Bethesda), 93: 178-193, 2001.
18. Bramhall, S. R., Stamp, G. W., Dunn, J., Lemoine, N. R., and Neoptolemos, J. P. Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br. J. Cancer, 73: 972-978, 1996.
19. Seiki, M. Membrane-type matrix metalloproteinases. APMIS, 107: 137-143, 1999.
20. Kataoka, H., Seguchi, K., Inoue, T., and Koono, M. Properties of α1-antitrypsin secreted by human adenocarcinoma cell lines. FEBS Lett., 328: 291-295, 1993.
21. Kataoka, H., Uchino, H., Iwamura, T., Seiki, M., Nabeshima, K., and Koono, M. Enhanced tumor growth and invasiveness in vivo by a carboxyl-terminal fragment of α-proteinase inhibitor generated by matrix metalloproteinases: a possible modulatory role in natural killer cytotoxicity. Am. J. Pathol., 154: 457-468, 1999.
22. Andreasen, P. A., Egelund, R., and Petersen, H. H. The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol. Life Sci., 57: 25-40, 2000.
23. Devy, L., Blacher, S., Grignet-Debrus, C., Bajou, K., Masson, V., Gerard, R. D., Gils, A., Carmeliet, G., Carmeliet, P., Declerck, P. J., Noel, A., and Foidart, J. M. The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent. FASEB J., 16: 147-154, 2002.
24. McMahon, G. A., Petitclerc, E., Stefansson, S., Smith, E., Wong, M. K., Westrick, R. J., Ginsburg, D., Brooks, P. C., and Lawrence, D. A. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem., 276: 33964-33968, 2001.
25. Pepper, M. S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler. Thromb. Vasc. Biol., 21: 1104-1117, 2001.
26. Liotta, L. A., and Kohn, E. C. The microenvironment of the tumour-host interface. Nature (Lond.), 411: 375-379, 2001.
27. Pupa, S. M., Menard, S., Forti, S., and Tagliabue, E. New insights into the role of extracellular matrix during tumor onset and progression. J. Cell. Physiol., 192: 259-267, 2002.
28. Crawford, H. C., and Matrisian, L. M. Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis, 14: 234-245, 1994.
29. Nelson, A. R., Fingleton, B., Rothenberg, M. L., and Matrisian, L. M. Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol., 18: 1135-1149, 2000.
30. Saren, P., Welgus, H. G., and Kovanen, P. T. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol., 157: 4159-4165, 1996.
31. Bachem, M. G., Schneider, E., Gross, H., Weidenbach, H., Schmid, R. M., Menke, A., Siech, M., Beger, H., Grunert, A., and Adler, G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology, 115: 421-432, 1998.